Moreover, accumulating evidence suggests that the behavioral and neural effects of oxytocin in healthy individuals vary as a function of psychopathology relevant dimensions, like, for example, alexithymia [136], autism [137, 138], depression [139–141], anxiety [142, 143], or trauma-exposure [144, 145]. Here, OXT is linked to depressive symptom measurement.